Seres (MCRB) Stock: Here’s What You Need To Know

Seres Therapeutics (NASDAQ:MCRB) On Friday, Seres Therapeutics stock plummeted by 70% after the company reported that it had failed mid-stage trial in patients with Clostridium difficile infection or C. diff. The company has a big pipeline, but the problem is that the study that failed was the lead drug candidate. Thus, the reason why the … Read more

Tempered Expectations for Goldman Sachs Earnings

Goldman Sachs (GS) is expected to report earnings on Thursday, July 16th. The whisper number is $3.92, four cents ahead of the analysts’ estimate and showing some confidence from the WhisperNumber community. Whispers range from a low of $3.80 to a high of $4.10. Goldman has a 76% positive surprise history (having topped the whisper … Read more

Controversial Goldman Sachs Downgrades | BlackBerry (BBRY) | MannKind (MNKD)

Goldman Sachs is a well respected company that’s known to make moves in the market by analyzing and grading stocks. However, there have been quite a few Goldman Sachs downgrades that have been sparking quite a bit of controversy in the investing world. Two of the biggest being the downgrades of BlackBerry (BBRY) stock and … Read more

BioTech Stocks News | ZGNX | CYTX | ACAD | MNKD | GILD

Zogenix (ZGNX) Produces A Loss For Q4 And Sells Zohydro Zogenix (ZGNX) recently announced that in Q4, the company lost more than $20 million. Also Zogenix (ZGNX) announced that it would be selling its Zohydro ER business to Pernix Therapeutics (PTX). The sale price on the business is $100 million, with an added $283.5 million … Read more

Today’s Tech News | AAPL | BBRY | QIHU | BITA | TWTR

Apple (AAPL) Stock Didn’t Get The Spring Forward Reaction We Were Expecting Apple’s big day was yesterday. Multiple key figures within the company got on center stage to discuss all of the latest product upgrades and additions to the Apple (AAPL) line up. For over a week, we anticipated the event; expecting amazing things to … Read more

BlackBerry (BBRY) Stock | Goldman Sachs Downgrades To Sell Rating!

BlackBerry (BBRY) has been a hot stock to follow recently. So, as I normally do, I started my day off on StockTwits, reading through the BlackBerry (BBRY) stream and other tech streams to see what was going on. The first thing that popped out to me was the fact that Goldman Sachs downgraded BlackBerry (BBRY) … Read more

This Week In Tech | AAPL | BBRY | PLUG | FB | GOOG

This week is going to be an exciting one for the tech junkies like myself. To get things rolling, we’ve got Spring forward in just a few hours and quite a bit going on elsewhere in tech. So, without further ado, let’s get right to it! Apple (AAPL) Stock To Start Strong With Spring Forward … Read more

MannKind (MNKD) Stock Crashes | Prescription Sales & Possible Price Reductions

MannKind (MNKD) has had an incredibly tough month in the market. Since February 10th, the stock has fallen from $7.58 per share to today’s (3.5.2015) active price of $5.76 per share; with a good portion of that drop happening this morning as Goldman Sachs downgraded the company’s stock. So, today, we’ll talk about the concerns … Read more